Javamide-II Inhibits IL-6 without Significant Impact on TNF-alpha and IL-1beta in Macrophage-Like Cells

The main aim of this study is to find a therapeutic compound to inhibit IL-6, not TNF-alpha and IL-1beta, in macrophage-like cells, because the high-levels of IL-6 production by macrophages are reported to cause unfavorable outcomes under several disease conditions (e.g., autoimmune diseases, and ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jae B., Peters, Renee, Pham, Quynhchi, Wang, Thomas T. Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344767/
https://www.ncbi.nlm.nih.gov/pubmed/32485858
http://dx.doi.org/10.3390/biomedicines8060138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344767/
https://www.ncbi.nlm.nih.gov/pubmed/32485858
http://dx.doi.org/10.3390/biomedicines8060138

Ejemplares similares